# Valproate Sodium Injection: FDA shortage status

> FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice.

- Derived status: current
- Source statuses: Current
- FDA package records: 2
- Latest FDA row update: 08/13/2026
- Retrieved: 2026-08-22T15:54:11+00:00

## FDA package and manufacturer records

- Fresenius Kabi USA, LLC — Valproate Sodium, Injection, 100 mg/1 mL (NDC 63323-494-05) — FDA availability: Available — updated: 08/04/2026
- Hikma Pharmaceuticals USA, Inc. — Valproate Sodium, Injection, 500 mg/5 mL (NDC 0143-9785-10) — FDA availability: Available — updated: 08/13/2026

## Sources and formats

- [FDA openFDA source](https://api.fda.gov/drug/shortages.json)
- [Canonical HTML](https://citefacts.com/shortages/valproate-sodium-injection)
- [JSON record](https://citefacts.com/shortages/valproate-sodium-injection.json)